GLG Pharma

GLG Pharma

Early Stage

Saving lives with next-generation ovarian cancer treatments.

Saving lives with next-generation ovarian cancer treatments.


Raised to Date: Raised: $0

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type


SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap




Rolling Commitments ($USD)

Not Funded
Reporting Date


Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise


Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Jupiter, Florida

GLG Pharma is an oncology company-- and they’re ready to improve cancer treatments. The current treatment for ovarian cancer only leads to about a 40% survival rate. However, GLG Pharma believes that by inhibiting STAT3, a mechanism found in over 30 types of cancer, they can help people respond more successfully to treatment by 10-20%. In fact, their goal is that, in the next five years with their research, they think they could raise the survival rate to 60-70%. So far, GLG was selected by the National Cancer Institute’s PREVENT Cancer Preclinical Drug Development Program for breast cancer, and they received a $3.7M grant from an EU supported fund in Poland for Triple Negative Breast Cancer treatment. Plus, the founder has already had nine drugs be approved by the FDA & EMA.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
GLG Pharma on Wefunder
Platform: Wefunder
Security Type: SAFE
Valuation: $15,000,000

Follow company

Follow GLG Pharma on Wefunder

Buy GLG Pharma's Deal Report

Warning: according to the close date for this deal, GLG Pharma may no longer be accepting investments.

GLG Pharma Deal Report

Get KingsCrowd’s comprehensive report on GLG Pharma including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether GLG Pharma is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the GLG Pharma deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge